Niva Bupa's Q4 profit jumps 31%. But margins raise a brow

Niva Bupa's stock gave investors a reason to smile, rallying 14 per cent on May 8 to hit Rs 92, its highest in nearly four months. The trigger? A solid 31 per cent jump in net profit for the March quarter. But behind the impressive headline number lies a few red flags that investors are now sniffing out. While revenue and premiums surged, operating margins slipped, and underwriting profits actually fell. That's not ideal for a health insurer trying to prove it can grow both fast and profitably. What Niva Bupa does Niva Bupa Health Insurance (formerly Max Bupa) is a standalone health insurer that offers retail and group health policies. It's a joint venture between UK-based Bupa and India's Fettle Tone LLP. The company went public in November 2024 with a modest premium listing. Since then, it's gained investor attention for its strong market presence and steady growth in retail health. What's driving the Niva Bupa share? Here's a snapshot of Niva Bupa's Q4 FY25: